We are live on
!
Find out more
Travere Therapeutics
TVTX
TVTX
165 hedge funds and large institutions have $807M invested in Travere Therapeutics in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 57 increasing their positions, 52 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 36
52% less call options, than puts
Call options by funds: $5.86M | Put options by funds: $12.1M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
165
Holding in Top 10
–
Calls
$5.86M
Puts
$12.1M
Top Buyers
| 1 | +$43.9M | |
| 2 | +$15.2M | |
| 3 | +$7.91M | |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$7.59M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$7.02M |
Top Sellers
| 1 | -$23.5M | |
| 2 | -$15M | |
| 3 | -$11M | |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$8.45M |
| 5 |
SCM
Sio Capital Management
New York
|
-$7.91M |